23 June 2022 - It was precisely 30 years ago, in 1992, that the FDA established the accelerated approval program ...
23 June 2022 - The US FDA on Thursday released draft guidance explaining its thought process for rescinding breakthrough therapy ...
15 June 2022 - PHARMAC today announces the first round of changes to medicines funding following its $191 million pharmaceutical ...
9 June 2022 - When he announced the government’s response to the recent independent review of PHARMAC Health Minister Andrew Little ...
4 June 2022 - When cancer drugs granted accelerated approval in the U.S. later turn out not to benefit patients, the ...
26 May 2022 - The mission of the National Institutes of Health is to translate scientific discovery into health by designing ...
25 May 2022 - Evidence about the relative effects of new treatments is typically collected in randomised controlled trials. ...
19 May 2022 - PHARMAC has issued three consultations today on proposals to fund medicines for conditions including cancer, multiple sclerosis, ...
5 May 2022 - NICE's expert group RAPID C-19, set up to ‘to ensure safe and timely patient access to treatments ...
4 May 2022 - Notwithstanding on-going confusion over the concepts of “real-world data” and “real-world evidence” in 2022, more than 5 ...
21 April 2022 - On March 30, an FDA advisory panel voted 6 to 4 against recommending approval of what ...
3 April 2022 - Decisions like this only reinforce the perception that Covid policy is driven by groupthink and politics. ...
9 February 2022 - Pharmaceutical industry officials are paying attention to how the Korean government will manage health insurance benefits ...
4 February 2022 - Our objective was to analyse and review consumer comments in the PBAC's decision-making process. ...
31 January 2022 - This study outlines the ways in which different health technology assessment organizations deal with uncertainty in relative ...